With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally ...

A high-pressure method of instantaneously freezing cells has proven to be effective in the first empirical validation of its ...

Gamida Cell (NASDAQ:GMDA) has entered into a restructuring support agreement with certain funds managed by Highbridge Capital Management, and will become a private company, wholly owned by Highbridge ...

Scientists have uncovered a previously unknown feature of cell death that reshapes how the immune system identifies and ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...

The International Society for Stem Cell Research (ISSCR) today announced that its official journal, Stem Cell Reports, has ...

The Zika virus, which is mostly transmitted by Aedes aegypti mosquitoes, emerged around 2007 to cause infections around the world, primarily in Asia, the Americas, and Pacific nations. There was a ...

Sharlin Health and Neurology Introduces New Stem Cell Therapy Program for Neurological Disorders in Ozark, MO Ozark, ...

High school teacher Marcus Mitchell, 35, is the first adult at Duke University Hospital to undergo this gene therapy aimed at ...